ArticleDisease markers2023

Retracted: Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma.

Disease MarkersPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.